HIGHLIGHTS
- who: September and collaborators from the China Nanjing Medical University, China have published the research work: The median effective doses of propofol combined with two different doses of nalbuphine for adult patients during painless gastroscopy, in the Journal: (JOURNAL) of 14/Nov/2021
- what: The study showed that 0.15 mg/kg nalbuphine leads to a significant reduction in the ED50 of propofol required to prevent cough or body movement during gastroscopy implantation in adult patients (BMI 18-24).
- future: Future studies should examine the dosages of nalbuphine combined with propofol among other . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.